Medicenna Therapeutics Corp.
MDNAF
$0.744
-$0.016-2.11%
Weiss Ratings | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.86 | |||
Price History | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.98% | |||
30-Day Total Return | -14.29% | |||
60-Day Total Return | -39.51% | |||
90-Day Total Return | -56.24% | |||
Year to Date Total Return | -33.27% | |||
1-Year Total Return | -35.14% | |||
2-Year Total Return | 32.86% | |||
3-Year Total Return | -45.69% | |||
5-Year Total Return | -54.36% | |||
52-Week High % Change | -66.18% | |||
52-Week Low % Change | 22.37% | |||
Price | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $2.20 | |||
52-Week Low Price | $0.61 | |||
52-Week Low Price (Date) | Mar 04, 2025 | |||
52-Week High Price (Date) | Jun 03, 2024 | |||
Valuation | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 58.03M | |||
Enterprise Value | 37.16M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.27 | |||
Earnings Per Share Growth | 65.49% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | 4.80 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $0.74 | |||
Enterprise Value/EBITDA (TTM) | -2.73 | |||
Enterprise Value/EBIT | -2.73 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 78.01M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 416 648 5555 | |||
Address | 2 Bloor Street West Toronto, ON M4W 3E2 | |||
Website | www.medicenna.com | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -42.57% | |||
Return on Equity | -- | |||
Income Statement | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -13.62M | |||
EBIT (TTM) | -13.63M | |||
Net Income (TTM) | -19.73M | |||
Net Income Avl. to Common (TTM) | -19.73M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -1.37% | |||
EPS Diluted (TTM) | -0.27 | |||
EPS Diluted Growth (Q YOY) | 9.52% | |||
Balance Sheet | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 20.85M | |||
Cash Per Share (Q) | $0.27 | |||
Total Current Assets (Q) | 22.25M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 12.13M | |||
Current Ratio (Q) | 10.086 | |||
Book Value Per Share (Q) | $0.16 | |||
Total Assets (Q) | 22.41M | |||
Total Current Liabilities (Q) | 2.21M | |||
Total Debt (Q) | 120.90K | |||
Total Liabilities (Q) | 10.28M | |||
Total Common Equity (Q) | 12.13M | |||
Cash Flow | MDNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -24.20K | |||
Cash from Financing (TTM) | 17.15M | |||
Net Change in Cash (TTM) | 5.96M | |||
Levered Free Cash Flow (TTM) | -8.36M | |||
Cash from Operations (TTM) | -11.95M | |||